THE PROCTER AND GAMBLE COMPANY for THE PROCTER AND GAMBLE COMPANY
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
-OECD Digital Tax Project (Global Minimum Tax Implementation) -S. 2003 (Strengthening Benefit Plans Act of 2025) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT CUSMANO | — |
Health Issues HCR
-H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. -Issues related to the inclusion of ingredients in over-the-counter products -H.R. 1219, Oral Health Products Inclusion Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA LOTSPIKE | — |
Chemicals/Chemical Industry CHM
- Issues Related to updating the Toxic Substances Control Act (No Bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW DAVID BISENIUS New | — |
Environment/Superfund ENV
- Issues related to plastics recycling - Issues related to sustainability (no bill) - H.R. 2269/S. 1092 - Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW DAVID BISENIUS New | — |
| TARA HOGAN CHARLES | — |
| ROBERT CUSMANO | — |
Pharmacy PHA
-Issues related to FDA review of active ingredients in over-the-counter products
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA LOTSPIKE | — |
Trade (domestic/foreign) TRD
- U.S. Manufacturing Policy and the USMCA - Industrial Machinery Section 232 Investigation - Issues related to America First Trade Policy/IEEPA Tariffs Executive Orders - China 301 Tariffs, Export Controls, Sanctions - Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) - Personal Protective Equipment and Medical Equipment Section 232 Investigation - Softwood Lumber Section 232 Investigation - Pharmaceuticals Section 232 Investigation - Semiconductors Section 232 Investigation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW DAVID BISENIUS | — |
| TARA HOGAN CHARLES | — |
| NICOLE C COLLIER | — |
| ROBERT CUSMANO | — |
| CHRISTINA LOTSPIKE | — |
| SEAN ROBERT MULVANEY | — |
Trucking/Shipping TRU
-Issues Related to Gross Vehicle Weight Limits (no bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT CUSMANO | — |
Foreign Relations FOR
-Issues related to Asia-Pacific Economic Cooperation (APEC)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN ROBERT MULVANEY | — |
Consumer Issues/Safety/Products CSP
- Issues Related to Product Safety and Quality Assurance (No Bill) - FDA Menstrual Products Guidance
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW DAVID BISENIUS | — |
| TARA HOGAN CHARLES | — |
| NICOLE C COLLIER | — |
| ROBERT CUSMANO | — |
| JULIA HENSON | — |
Food Industry (safety, labeling, etc.) FOO
-Issues related to Generally Recognized As Safe designation
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA LOTSPIKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.